This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/515409-france-one-dose-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| French health advisory body says single dose of Covid-19 vaccine is enough for people who previously caught virus | French health advisory body says single dose of Covid-19 vaccine is enough for people who previously caught virus |
| (30 days later) | |
| France’s public health authority HAS (Haute Autorité de Santé) has recommended that just one shot of a Covid-19 vaccine be given to people who have previously contracted the virus, instead of the two currently being administered. | France’s public health authority HAS (Haute Autorité de Santé) has recommended that just one shot of a Covid-19 vaccine be given to people who have previously contracted the virus, instead of the two currently being administered. |
| People who have already caught Covid-19 should wait for three to six months before being immunized with a single dose, but not longer, the HAS said in an opinion released on Friday. | People who have already caught Covid-19 should wait for three to six months before being immunized with a single dose, but not longer, the HAS said in an opinion released on Friday. |
| The HAS is a scientific advisory body, meaning that the French government will now need to decide whether to deviate from France’s current vaccine rollout and take up its recommendation. | The HAS is a scientific advisory body, meaning that the French government will now need to decide whether to deviate from France’s current vaccine rollout and take up its recommendation. |
| France is rolling out three different two-dose Covid vaccines, made by Pfizer-BioNTech, Moderna, and the AstraZeneca/Oxford University partnership. | France is rolling out three different two-dose Covid vaccines, made by Pfizer-BioNTech, Moderna, and the AstraZeneca/Oxford University partnership. |
| The HAS statement says those who have tested positive for Covid-19 are protected by an "immunity memory" for at least three months, meaning that a single vaccine dose effectively acts as a "booster" jab. | The HAS statement says those who have tested positive for Covid-19 are protected by an "immunity memory" for at least three months, meaning that a single vaccine dose effectively acts as a "booster" jab. |
| Exceptions to the proposed dosing regimen include those who have caught Covid in the days after they received their first dose of a vaccine and people with immunosuppressive conditions, who should be vaccinated with two doses. | Exceptions to the proposed dosing regimen include those who have caught Covid in the days after they received their first dose of a vaccine and people with immunosuppressive conditions, who should be vaccinated with two doses. |
| The recommendations state that those who are infected soon after being immunized should wait three to six months after being infected before receiving their second vaccine dose. | The recommendations state that those who are infected soon after being immunized should wait three to six months after being infected before receiving their second vaccine dose. |
| People most at risk of severe disease, such as the elderly and those with underlying health conditions, should still be prioritized to receive the protective jabs, according to HAS. | People most at risk of severe disease, such as the elderly and those with underlying health conditions, should still be prioritized to receive the protective jabs, according to HAS. |
| Under the proposal, people who suffered prolonged Covid symptoms would need to be individually assessed by a specialist before opting to take only a single shot of the vaccine. | Under the proposal, people who suffered prolonged Covid symptoms would need to be individually assessed by a specialist before opting to take only a single shot of the vaccine. |
| The HAS recommendations are based on the findings of the French-language Infectious Pathology Society (SPILF) and data regarding the Pfizer-BioNTech vaccine. | The HAS recommendations are based on the findings of the French-language Infectious Pathology Society (SPILF) and data regarding the Pfizer-BioNTech vaccine. |
| Since France launched its two-dose vaccination program on December 27, at least 2 million people have received their first dose and more than 500,000 have gotten a second jab. | Since France launched its two-dose vaccination program on December 27, at least 2 million people have received their first dose and more than 500,000 have gotten a second jab. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |